These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 6733990)

  • 1. Heparin activity during hemodialysis.
    Simons O
    Clin Nephrol; 1984 Apr; 21(4):247. PubMed ID: 6733990
    [No Abstract]   [Full Text] [Related]  

  • 2. The safety of heparins in end-stage renal disease.
    Sonawane S; Kasbekar N; Berns JS
    Semin Dial; 2006; 19(4):305-10. PubMed ID: 16893408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodialysis without heparin infusion using Cordis Dow 3500 hollow fiber.
    Raja R; Kramer M; Rosenbaum JL; Bolisay C; Krug M
    Proc Clin Dial Transplant Forum; 1980; 10():39-42. PubMed ID: 7346852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lowering of the dosage of intravenous heparin hemodialysis by priming with subcutaneous heparin.
    Jespersen J; Gregersen G
    Clin Nephrol; 1981 Nov; 16(5):270. PubMed ID: 7307356
    [No Abstract]   [Full Text] [Related]  

  • 5. Heparin usage in chronic hemodialysis.
    Lewis LM
    Nephrol Nurse; 1981; 3(2):33, 47. PubMed ID: 6907680
    [No Abstract]   [Full Text] [Related]  

  • 6. [Heparin in pregnant women undergoing hemodialysis. Doses according to heparin kinetic models].
    Downey P; López ME
    Rev Med Chil; 1993 Jun; 121(6):703-4. PubMed ID: 8278710
    [No Abstract]   [Full Text] [Related]  

  • 7. Whole-blood activated coagulation time for evaluation of heparin activity during hemodialysis: a comparison of administration by single-dose and by infusion.
    Wilhelmsson S; Lins LE
    Clin Nephrol; 1983 Feb; 19(2):82-6. PubMed ID: 6839556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Total heparinization in hemodialysis].
    Trikashnyĭ AA
    Eksp Khir Anesteziol; 1971; 16(1):49-51. PubMed ID: 5136518
    [No Abstract]   [Full Text] [Related]  

  • 9. [The resistance of activated partial thromboplastin time to heparin infusion during hemodialysis].
    Camici M; Sagripanti A; Barsotti G; Baicchi U; Evangelisti L; Morelli E; Giovannetti S
    Minerva Med; 1995 Sep; 86(9):353-5. PubMed ID: 7501225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Indications and technic for regional heparinization during hemodialysis].
    Bruschi E; Ancona G; Galanti G; Dalla Rosa C; Confortini P
    Minerva Med; 1967 Jun; 58(45):2109-10. PubMed ID: 6028369
    [No Abstract]   [Full Text] [Related]  

  • 11. Thromboxane B2 blood levels and incipient system clotting in heparin free hemodialysis.
    Keller F; Hericks K; Schuller I; Passfall J; Joerres A; Meinhold H
    ASAIO J; 1995; 41(2):173-7. PubMed ID: 7640422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Method of evaluating the adequacy of heparinization during hemodialysis].
    Sukhanov VA; Zlokazov VB
    Urol Nefrol (Mosk); 1982; (3):42-4. PubMed ID: 7112773
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of heparin in the changes of lipid patterns during a single hemodialysis.
    Teraoka J; Matsui N; Nakagawa S; Takeuchi J
    Clin Nephrol; 1982 Feb; 17(2):96-9. PubMed ID: 6802545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin therapy in routine hemodialysis.
    Pittard JD
    Nephrol News Issues; 2001 Apr; 15(5):73-5. PubMed ID: 12108969
    [No Abstract]   [Full Text] [Related]  

  • 15. Sampling for international normalized ratios in patients on hemodialysis with central venous catheters.
    Boyd A; Dunne A; Townsend K; Pai AB
    Nephrol Nurs J; 2006; 33(4):408-11. PubMed ID: 17001998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dialyzer fiber bundle volume during hemodialysis using large-surface dialyzers.
    Leblanc M; Lafrance JP; Renald A
    ASAIO J; 2006; 52(6):646-51. PubMed ID: 17117054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of fibrinopeptide A in the evaluation of heparin activity and fibrin formation during hemodialysis.
    Wilhelmsson S; Asaba H; Gunnarsson B; Kudryk B; Robinson D; Bergström J
    Clin Nephrol; 1981 May; 15(5):252-8. PubMed ID: 7249422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a sliding scale protocol for heparin on the ability to maintain whole blood activated partial thromboplastin times within a desired range in hemodialysis patients.
    Low CL; Bailie G; Morgan S; Eisele G
    Clin Nephrol; 1996 Feb; 45(2):120-4. PubMed ID: 8846524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anticoagulation in hemodialysis with a single dose of low molecular weight heparin].
    Vukusich A; Avalos C; Orellana G; Cifuentes C; Rivas J; Calderón F
    Rev Med Chil; 1995 Jun; 123(6):735-41. PubMed ID: 8525227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [When lipids increase in dialysis: the role of heparin! Standard heparin increases, low-molecular-weight heparin lowers triglycerides].
    Wiemer J; Scherberich JE
    MMW Fortschr Med; 1999 Oct; 141(43):29-32. PubMed ID: 10912118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.